Ping Chi
, Lab Program Director · New York Presbyterian Hospital
Credentials: · · · ·
History
Present- Present
Sarcoma Translational Research · New York Presbyterian Hospital
1999–2003
Research
OncoKB: A Precision Oncology Knowledge Base
JCO Precision Oncology · 2017 · 2,318 citations
Organoid cultures derived from patients with advanced prostate cancer
Cell · 2014 · 1,236 citations
Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers
Review · Nature reviews. Cancer · 2010 · First of 3 authors · 868 citations
- CA
50 papers
- WT
47 papers
37 papers
- MK
35 papers
35 papers · 1 as a fellow
- SD
35 papers · 17 as a resident
- MD
34 papers
- CK
29 papers
Grants
- 2018–2029
National Cancer Institute · P50
Project lead · $1.4M · Sloan-Kettering Inst Can Research
- 1985–2028
Clinical Scholars Biomedical Research Training Program
National Cancer Institute · T32
Contact PI · $3M · Sloan-Kettering Inst Can Research
- 2023–2028
Harnessing Double Stranded-RNA (dsRNA)-Response and Anti-Tumor Effect in PRC2-Inactivated Cancer
National Cancer Institute · R01
Contact PI · $2.9M · Sloan-Kettering Inst Can Research
- 2022–2027
Phase II Study of ASTX727 in Patients with PRC2 Loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
Food and Drug Administration · R01
Contact PI · $1.6M · Sloan-Kettering Inst Can Research
Clinical trials
- 2021–2027
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
- 2017–2021
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
- 2013–2026
Principal investigator · Active not recruiting · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
- 2023–2029
Site PI · Recruiting · Phase 1, Phase 2
Deciphera Pharmaceuticals, LLC